Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Inclusion Criteria:

• Signed and dated informed consent

• Male or female aged from ≥ 18 years old.

• Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior tostudy selection.

Exclusion Criteria:

• Best far corrected visual acuity < 1/10

• Severe blepharitis

• Severe Dry Eye

• Eyelid malposition

• Known hypersensitivity to one of the components of the study medications or testproducts.

• Pregnant or breast-feeding woman.

• Woman of childbearing age (neither menopausal, nor hysterectomised, nor sterilized)not using effective contraception (oral contraceptives, intra-uterine device,contraceptive implant or condoms).

• Inability of patient to understand the study procedures and thus inability to giveinformed consent.

• Non compliant patient (e.g. not willing to attend the follow-up visits, way of lifeinterfering with compliance).

• Already included once in this study.

• Patient under guardianship.